Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Sales | 172,698 | 183,526 | 172,286 | 165,725 | 160,950 |
| Cost of Goods | 63,224 | 63,944 | 63,021 | 59,805 | 58,148 |
| Gross Profit | 109,474 | 119,582 | 109,265 | 105,920 | 102,802 |
| Operating Expenses | 87,055 | 92,679 | 85,466 | 82,820 | 80,698 |
| Operating Income | 22,643 | 27,847 | 23,820 | 23,905 | 22,252 |
| Interest Expense | 4,541 | 4,876 | 5,493 | 6,174 | 6,684 |
| Other Income | 1,207 | -294 | -183 | -347 | -621 |
| Pre-tax Income | 19,309 | 22,677 | 18,144 | 17,384 | 14,947 |
| Income Tax | 4,087 | 6,946 | 3,712 | 6,159 | 5,380 |
| Net Income Continuous | 15,222 | 15,731 | 14,432 | 11,225 | 9,567 |
| Net Income | $15,222 | $15,731 | $14,432 | $11,225 | $9,567 |
| EPS Basic Total Ops | 0.26 | 0.28 | 0.25 | 0.19 | 0.17 |
| EPS Basic Continuous Ops | 0.26 | 0.27 | 0.25 | 0.19 | 0.17 |
| EPS Diluted Total Ops | 0.25 | 0.28 | 0.25 | 0.19 | 0.16 |
| EPS Diluted Continuous Ops | 0.25 | 0.27 | 0.25 | 0.19 | 0.16 |
| EBITDA(a) | $32,431 | $40,866 | $34,312 | $32,982 | $31,752 |